StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Charles River Laboratories International, Inc.
NYSE:CRL
Sector
Industries
Location
Market Cap
USD 8.04 B
Share Price
USD 163.66
Avg Daily Volume
1,537,950
Change (1 day)
2.95%
Change (1 year)
-19.26%
Change (YTD)
-11.34%
Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 29, 2025: 3.71%
Charles River Laboratories International, Inc. EBIT Margin is 3.71% for the Trailing 12 Months (TTM) ending March 29, 2025, a -77.78% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 30, 2024 was 16.70%, a -10.73% change year over year.
-
Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending April 01, 2023 was 18.71%, a 15.15% change year over year.
-
Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 26, 2022 was 16.24%, a -9.12% change year over year.
-
Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 27, 2021 was 17.87%, a 29.82% change year over year.
Competitors
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Siemens Healthineers AG
USD 55.98
SHL.DE
+0.43
0.78%
Regeneron Pharmaceuticals, Inc.
USD 559.76
REGN
+7.18
1.30%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Siemens Healthineers AG
USD 55.98
SHL.DE
+0.43
0.78%
Regeneron Pharmaceuticals, Inc.
USD 559.76
REGN
+7.18
1.30%